WebYttrium-90 has a half-life of approximately 2.5 days; therefore, 94% of the radiation is delivered to the tumor within 11 days following treatment. ... SIR-Spheres Y 90 resin microspheres are indicated for the treatment of unresectable hepatocellular carcinoma (HCC) and unresectable metastatic liver tumors from primary colorectal cancer in ... WebSIR-Spheres will have the following indication for use: SIR-Spheres Y 90 resin microspheres are indicated for the treatment of unresectable hepatocellular carcinoma (HCC) or … About SIR-Spheres . SIR-Spheres Y-90 resin microspheres are a permanent implant … Product Ordering - Sirtex - SIR-Spheres® Y-90 Resin Microspheres Address: Phone: Sirtex Medical Inc. 300 Unicorn Park Drive Woburn MA 01801 … Professionals - Sirtex - SIR-Spheres® Y-90 Resin Microspheres News - Sirtex - SIR-Spheres® Y-90 Resin Microspheres
microspheres - Sirtex
WebSIR-Spheres® Y-90 resin microspheres (Yttrium-90 microspheres) 1 Description SIR-Spheres microspheres consist of biocompatible microspheres containing yttrium-90 with a size between 20 and 60 microns in diameter. Yttrium-90 is a high-energy pure beta-emitting isotope with no primary gamma emission. The maximum energy of WebYttrium-90 is produced by the nuclear decay of strontium-90 which has a half-life of nearly 29 years and is a fission product of uranium used in nuclear reactors. As the strontium-90 decays, chemical high-purity separation is used to isolate the yttrium-90 before precipitation. [7] [8] cultural humility self reflection
NCCN Guidelines® Recommend SIR-Spheres® Y-90 Resin Microspheres
WebTheraSphere consists of insoluble glass microspheres where yttrium-90 is an integral constituent of the glass. The product is injected by a physician into an artery of the patient’s liver through a catheter, which allows the treatment to be delivered directly to the tumor via blood flow. The microspheres, being unable WebApr 24, 2024 · "Neither sorafenib nor SIR-Spheres Y-90 resin microspheres produced a statistically significant difference in Overall Survival (OS) of the patients we studied," said Prof. Vilgrain. "Despite 26.6% ... WebApr 25, 2024 · National Health Service (NHS) England have announced that selective internal radiation therapy (SIRT) using yttrium-90 (Y-90) microspheres will now be routinely commissioned for NHS patients with advanced colorectal cancer that has spread to the liver and is not responding to standard chemotherapies. eastlion store